SynopsisHydroxychloroquine is a drug used to prevent and treat certain types of malaria. Specifically, it is used for chloroquine-sensitive malaria. Other uses include the treatment of rheumatoid arthritis, lupus and cutaneous porphyria. It is also used as an experime.....
SynopsisDue to the COVID-19 pandemic, the global Gingivitis Irrigator market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the e.....
SynopsisThe global Chimeric Antigen Receptor Cell Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD .....
SynopsisThe global Restriction Enzyme market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Restriction Enzyme is estimated to increase fro.....
SynopsisAs for March, 26 2020: Dr. Eleanor Fish (a prominent immunologist at the University of Toronto, Canada) comments that she does not think BCG may completely eliminate infection caused by a novel coronavirus, but it is likely to mitigate the effect.....
SynopsisThe global Plastic Tongue Depressors market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Plastic Tongue Depressors is estimated t.....
SynopsisLurasidone, sold under the trade name Latuda among others, is an antipsychotic medication used to treat schizophrenia and bipolar disorder. In bipolar it may be used together with a mood stabilizer such as lithium or valproate. It is taken by mouth. The .....
SynopsisOPDIVO® (nivolumab) is a prescription medication that treats certain types of cancer. The global Nivolumab Drugs market was valued at US$ 9567 million in 2023 and is anticipated to reach US$ 15620 million by 2030, witnessing a CAGR of 6.8% during the for.....
SynopsisContrast media (or contrast agents) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, .....
SynopsisAcute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It.....
